Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
On June 26, 2024, Clover Health announced that it has regained compliance with the Nasdaq minimum bid price requirement. The company had previously received a notice on April 2, 2024, from Nasdaq, indicating that its stock price had fallen below the required $1.00 per share. To comply, Clover Health's Class A Common Stock needed to maintain a closing bid price of at least $1.00 for 10 consecutive trading days, which it successfully achieved by June 25, 2024. Nasdaq has officially informed Clover Health that the matter is now resolved.
- Clover Health has regained compliance with Nasdaq's minimum bid price requirement.
- The company's stock maintained a closing bid price of at least $1.00 for 10 consecutive trading days.
- The company had previously fallen below the $1.00 per share required minimum bid price, prompting a compliance notice from Nasdaq on April 2, 2024.
FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1).
As previously disclosed, the Company received a written notice from Nasdaq on April 2, 2024, notifying the Company that it had failed to meet the
To regain compliance with the Listing Rule, the Company’s Class A Common Stock was required to maintain a minimum closing bid price of
To learn more about Clover Health, visit: investors.cloverhealth.com.
Forward-Looking Statements
Please note that this press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events and Clover Health’s future results of operations, financial position, business strategy and future plans. Forward-looking statements are not guarantees of future performance, and you are cautioned not to place undue reliance on such statements. In some cases, you can identify forward looking statements because they contain words such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “going to,” “can,” “could,” “should,” “would,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “outlook,” “forecast,” “guidance,” “objective,” “plan,” “seek,” “grow,” “target,” “if,” “continue,” or the negative of these words or other similar terms or expressions that concern Clover Health’s expectations regarding continued future compliance with Nasdaq listing requirements. These statements are subject to known and unknown risks, uncertainties and other factors that may cause Clover Health’s actual results, levels of activity, performance or achievements to differ materially from results expressed or implied in this press release. Additional information concerning these and other risk factors is contained in Clover Health’s latest Annual Report on Form 10-K filed with the SEC on March 14, 2024, and in our subsequent reports filed with the SEC, in each case, including the Risk Factors section therein, and in its other filings with the SEC. The forward-looking statements included in this press release are made as of the date hereof. Except as required by law, Clover Health undertakes no obligation to update any of these forward-looking statements after the date of this press release or to conform these statements to actual results or revised expectations.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. Clover has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
FAQ
Did Clover Health regain compliance with Nasdaq's minimum bid price requirement?
What was the minimum bid price requirement that Clover Health needed to meet?
When did Clover Health receive notice of non-compliance from Nasdaq?
What is the stock symbol for Clover Health?
When did Clover Health achieve the minimum bid price requirement?
